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Improving the Nutrient Content of Food through
Genetic Modification: Evidence from Experimental
Auctions on Consumer Acceptance
Gregory J. Colson, Wallace E. Huffman, and Matthew C. Rousu
This paper assesses consumers’ acceptance of nutritionally enhanced vegetables using a series of
auction experiments administered to a random sample of adult consumers. Evidence suggests that
consumers are willing to pay significantly more for fresh produce with labels signaling enhanced
levels of antioxidants and vitamin C achieved by moving genes from within the species, as
opposed to across species. However, this premium is significantly affected by diverse information
treatments injected into the experiments.
Key words: Bayesian analysis, experimental auction, food products, genetic modification
Introduction
Daily consumption of fruits and vegetables in the United States is significantly lower than national
dietary recommendations, despite extensive information campaigns, outreach efforts, and popular-
media attention highlighting the relationship between food choices and health outcomes (Guenther
et al., 2006; Kimmons et al., 2009). Fruits and vegetables are promoted in the battle against obesity
as a superior alternative to high-caloric foods (e.g., sugar based beverages, calorie-dense processed
snacks). They are also a natural source of the vitamins, minerals, and antioxidants that play a critical
role in determining health outcomes (e.g, Block, Patterson, and Subar, 1992; Joshipura et al., 2001;
Epstein et al., 2001), but the proliferation of foods fortified or enriched with vitamins and minerals
(e.g., breakfast cereals) and daily multivitamin tablets has diminished this role (Subar et al., 1998;
Berner, Clydesdale, and Douglass, 2001).1 The emergence of non-food sources of nutrients coupled
with the burgeoning success of the functional food market has helped motivate the biotechnology
industry to develop new crop varieties engineered for superior nutrient levels, such as potatoes with
enhanced levels of antioxidants and vitamin C.
While genetic modification has potential for delivering improved product quality by enhancing
nutrient content, since their emergence in the market in the mid-1990s genetically modified (GM)
foods have remained domestically and internationally a socially and politically sensitive topic due to
their perceived unnatural production. Early GM foods were engineered using “transgenic” methods,
in which genes from one species are transferred into a different species (e.g., from soil bacteria into
corn). Studies have shown that consumers view these transgenic foods as weakly inferior to similar
non-GM alternatives (e.g., Huffman et al., 2003; Noussair, Robin, and Ruffieux, 2004; Lusk et al.,
2005; Rousu et al., 2007). The transgenic nature of these genetically modified organisms (GMOs)
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has been one dimension of consumers’ and environmental groups’ resistance to genetic modification
of plants–raising biodiversity, environmental, ethical, and safety concerns–and has been a factor in
the larger controversy surrounding GMOs (for reviews of the GM debate see Herdt, 2006; van den
Bergh and Holley, 2002).
To counter some of these concerns, new “intragenic” bioengineering methods have been
developed that only transfer genes from within the species (e.g., from a wild potato variety into a
commercial potato variety), exploiting the natural and induced diversity of species that has evolved
over time in diverse geo-climates. The traditional method of slicing genes includes the use of
antibiotic markers, which mark the location of a transgene on chromosomes, but this practice has
raised public concern. A new gene transfer system has been developed that does not infringe on
existing gene splicing patents and does not use antibiotic markers (see Rommens et al., 2004). No
“foreign” genetic material is used in this new gene transport system, removing one of the perceived
negative attributes of earlier transgenic foods. Moreover, the new method has many features in
common with traditional plant breeding methods.
This study examines consumers’ willingness to pay for foods that have been enhanced with
consumer attributes–vitamins and antioxidants–delivered by transgenic and intragenic GM methods
controlling for information effects. The study uses an auction market mechanism for revealing
willingness to pay and participants randomly chosen from consumers in two urban areas. Building
on the methodology of Rousu et al. (2007), food labels and information treatments are an important
part of the research design. As an additional advance in analyzing experimental auction bid-price
data, we construct and estimate a Bayesian econometric model of bid prices that simultaneously
controls for bid censoring, commodity fixed effects, bidding-round fixed effects, and correlation of
unobserved effects across rounds of bidding.
Experimental Design
In spring 2007, an independent survey agency called a random set of telephone numbers in two
cities to solicit participants for our experiments. Participants were chosen from two geographically
separated cities to obtain some regional balance in our participants, and they were only told that
this was a university project on consumers’ assessments of household products and foods. Willing
participants were then permitted to chose among three or four starting times on the auction days
(March 24 in Harrisburg, Pennsylvania, and April 14 in Des Moines, Iowa; both dates were
Saturdays), and they were given instructions on how to reach the lab site or classroom. In our
experiments, we disseminate several information treatments randomly within the same session to
avoid potentially confounding session effects.
Our methodology incorporated and refined established experimental procedures (Hoffman et al.,
1993; Shogren et al., 1994; Lusk et al., 2001; Alfnes and Rickertsen, 2003) and advances made by
Rousu et al. (2007). We used adult consumers from two distinct geographic regions that were drawn
from a random phone book sample, ensuring that our results are not artifacts of a single geographic
region. We paid participants a fixed amount for participating in the experiments, but do not endow
participants with products and have them bid to upgrade to another product, because new evidence
by Corrigan and Rousu (2006) and Plott and Zeiler (2007) has shown that session monitors in the
past may have induced significant endowment effects in bid prices by emphasizing the personal gift
nature of in-kind transfers made to participants as part of the experiment. To assess the impact of
interested parties (e.g., biotechnology, environmental, and independent scientific groups) attempting
to impact market outcomes by strategically using private information (Milgrom and Roberts, 1986),
we injected randomized information treatments into the experiments. We used the nth-price auction
mechanism (Shogren et al., 2001), which has been shown to be a demand revealing mechanism that
better engages off-margin bidders. To avoid strategic behavior in bidding in sequential price auctions
(Bajari and Hortaçsu, 2003; Guerre, Perrigne, and Vuong, 2000; Corrigan and Rousu, 2006), all bids
are collected in a session before any information about the bid levels and distributions are revealed.
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We also randomized all food labels to eliminate sequencing effects. Finally, in many previous
experiments where information is disseminated to participants (Lusk et al., 2004; Rousu et al., 2007),
each “session” receives the same information treatment. In our experiments, we disseminate several
information treatments randomly within the same session, thus avoiding potentially confounding
session effects.
Upon arrival at the experiment site, participants were alternately assigned to one of two
concurrent sessions (related individuals were assigned to different sessions). Each session consisted
of nine to seventeen individuals and lasted approximately ninety minutes. Participants were asked
to sign a consent form and were paid $45 dollars for their participation. Next, they were asked
to complete a short questionnaire soliciting socioeconomic and demographic information and to
answer a few questions about agricultural technologies. A total of fourteen sessions (eight in Des
Moines and six in Harrisburg) were conducted. With regards to the location for experiments, it
should be noted that many experimental studies are now being conducted in settings that are more
familiar to consumers (Lusk, Pruitt, and Norwood, 2006). We also considered the possibility of using
an intercept sample in a grocery store in a “framed field experiment” (Harrison and List, 2004), but
the length of the experiment prohibited that option.
Participants were informed that they would be engaging in an auction of food products and
provided with instructions and examples about the auction method used in the study: the nth-price
auction. In this type of auction, all individuals who bid higher than the randomly selected “nth-
price” win the auction and pay the nth-price for the commodity. Instead of using the more common
Vickrey sealed bid second-price auction mechanism (Vickrey, 1961), the nth-price auction was
selected based on evidence that it better engages off-margin bidders while still being a demand-
revealing mechanism. The Becker and Marschak (1964) mechanism is also demand-revealing (e.g.,
Wertenbroch and Skiera, 2002), but the random nth-price auction has been shown to be more
accurate at revealing preferences in experiments, potentially due to the endogenous clearing price
(Lusk and Rousu, 2007). As part of the instruction process, participants were told that their preferred
strategy should be to bid their true preferences.
During a practice phase, participants engaged in a two-round nth-price auction with candy, pens,
and pencils to gain experience with the nth -price auction. Participants were then told that the auction
would consist of four rounds of bidding, but only one round would be binding and it would be
chosen after all bids were submitted. This format reduces participants’ concerns about exceeding
their resources (the $45 dollars plus any cash they brought with them to the experiment) and fixes the
idea that despite multiple bidding rounds they are bidding on only one unit of each of the auctioned
commodities, eliminating potential demand effects associated with multiple purchases.
Three information perspectives on GMOs and a “no information” baseline were used to construct
five information treatments for the experiments. The pro-biotech perspective consists of a collection
of mainly positive or optimistic statements on GM provided by a group of leading agricultural
biotechnology companies. The anti-biotech perspective consists of a collection of mainly negative
or pessimistic statements on GM from leading environmental groups. The third-party perspective
(or verifiable information) is a collection of statements representing an objective assessment of GM
at the time the experiments were conducted. This perspective was linked to scientists, professions,
religious leaders and academics, none of whom had a financial stake in GM foods. To ensure that
the volume of information contained in the three perspectives on GMOs was not overwhelming to
participants, each perspective was limited to one standard sheet of copy paper and organized under
five common headings. The three information perspectives are presented in the appendices. The
order of pro- and anti-biotech perspectives was randomized in treatments consisting of more than
one perspective. The verifiable perspective was always presented last. Throughout this article, the
following terms will be used synonymously to refer to types of information: 1) industry, positive,
pro-biotech, 2) environmental, negative, and anti-biotech, and 3) verifiable and third party.
In each round of the auction, participants submitted three separate bids: one bid for each of the
three auction commodities. The auction commodities were one pound of broccoli, one pound of
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Figure 1. Examples of Auction Food Labels for Products without Enhanced Nutrients
Figure 2. Examples of Auction Food Labels for Products with Enhanced Nutrients
beefsteak tomatoes, and five pounds of russet potatoes. Products were presented in plain packaging
similar to how they are displayed in a grocery store, and a simple label was affixed. In each bidding
round, the three commodities with labels were revealed on a table in the front of the lab. In half of the
sessions (3 in PA and 4 in IA), the four food labels (one in each round) were: GM Free, Intragenic
GM, Transgenic GM, and Plain. Product name (e.g. Russet Potatoes) and weight were listed on each
label. The phrase “Plain” describes a label containing only the product name and weight. Figure 1
presents examples of labels. In the other half of the sessions (seven total), the first three rounds of
the auction consisted of products with food labels of either GM, Intragenic GM, or Transgenic GM,
but also offered additional information: “Enhanced levels of Antioxidants and Vitamin C.” Figure
2 presents examples of these labels. A fourth label treatment, not pertinent to this article, always
appeared in the final auction round and would not affect bids in the earlier three rounds.
All three products within a round of bidding had the same food label, and the order in which
labels were presented was randomized across sessions. After a set of experimental products was
revealed, participants were asked to come to the front of the room and view the products before
writing their three bids. These bids were then collected by the session monitor before proceeding to
the next round of bidding.
After completion of all bidding rounds, the binding bidding round was selected by drawing a
number from an envelope. Bids were then posted and ranked on a whiteboard in the front of the
lab (no bids were posted prior to this point). Finally, for each of the three commodities a random
n was drawn from an envelope to determine the clearing prices. Winners were then identified.
All participants were then asked to complete a short exit questionnaire. Upon completing the
questionnaire, non-winners were told that they were free to leave, and winners were told to go to
an adjacent room to complete their purchases, exchanging money for goods. Given the incomplete
regulatory status of the intragenic foods, we were unable to deliver nutrient-enhanced GM fresh
vegetables to winners. As an alternative, winners were informed and given plain-labeled food
products, which is similar to procedures followed by others in similar circumstances (e.g., Alfnes
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Table 1. Summary Statistics for Auction Participants (N=190)
Variable Variable Definition Mean Stdev
Gender 1 if female 0.68 0.47
Age Participant’s age 44.33 15.8
Income Household income (in 1000s) 51.09 35.23
Education Years of schooling 14.47 2.26
Married 1 if married 0.53 0.50
Household Number of people in household 2.74 1.41
Race 1 if participant is white 0.85 0.36
Informed 1 if well or extremely well informed about GM 0.11 0.31
Opinion 1 if opinion towards GM is supportive 0.17 0.38
Read_Labels 1 if often or always read food labels 0.63 0.48
Envi_Mem 1 if member of environmental group 0.04 0.20
Farm 1 if previously/currently engaged in farming 0.04 0.21
Smoke 1 if smoke 0.23 0.42
Exercise 1 if exercise regularly 0.51 0.51
Health_Diet Self assessed healthiness of diet (1-10 scale) 6.73 1.61
Health_Phys Self assessed physical health (1-10 scale) 7.16 1.69
and Rickertsen, 2003; Corrigan et al., 2009; Tonsor et al., 2005). Participants’ reception to these
experiments was very good, and we did not receive any complaints.2
Summary of Data
Table 1 presents basic summary statistics of the auction participants. Participants are 68% female,
the mean age is 44 years, mean education is 14.5 years, and mean household income is $51,000.
Only 11% of the participants consider themselves well- or extremely well-informed about GM, and
17% report an opinion of GM that is supportive or strongly supportive. 63% report that they often or
always read food labels. Regarding lifestyle indicators, 23% report that they smoke and 51% report
exercising regularly. Participants self-assessed the healthiness of diet with a mean score of 6.7 on a
scale of 1 to 10 and self-assessed their physical health with a mean of 7.2.
Tables 2 and 3 summarize participants’ bid prices for fresh produce in the experimental auctions.
Table 2 contains the mean and standard deviation (in parentheses) of bid prices for products without
enhanced nutrient labels, conditional on information treatments. Table 3 presents similar summary
statistics for products with enhanced nutrient labels. Fewer than 8% of placed bids were zeros. For
products without enhanced nutrient labels, the mean bid pooled across all information treatments
for products labeled GM Free is greater than for Plain-labeled products; similarly, Plain-labeled
products had a higher mean bid than products labeled as Transgenic GM. The ordering of mean
bid prices for the Plain label and Intragenic GM label is not the same across products. For products
with enhanced nutrient labels, mean bid prices for Intragenic GM labeled products pooled across all
2 Some of the food labels for fresh vegetables were different from the actual genetic make-up of the product. This
discrepancy was not perceptible to participants and no winner was misled about the product that he or she received at the end
of the experiment. Some call this practice “deception.” There is not much research on the effects of this type of deception, and
the few studies that have investigated it find small–if any–impact. Ethically, the benefits from this type of deception need to be
weighed against the costs. If university students are the participants and they participate repeatedly within the same lab, then
the practice is problematic to good research (e.g., Ortmann and Hertwig, 2002). However, when participants are randomly
drawn adults from the general population, the impact on future experimental participants is going to be very small. Some
argue for debriefing sessions at the end of experiments (Bonetti, 1998), but our experimental design, which was approved by
the ISU Institutional Review Board on Human Subjects, did not lend itself to a complete debriefing of non-winners.
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Table 2. Mean Bid Prices for Foods without Enhanced Nutrient Label
Broccoli (1 lb.) Tomato (1 lb.) Potato (1 lb.)
Plain GMF Intra Trans Plain GMF Intra Trans Plain GMF Intra Trans
All Treatments (N=92)
1.28 1.46 1.42 1.20 1.38 1.52 1.36 1.18 2.16 2.34 2.16 2.00
(0.76) (0.77) (0.86) (0.78) (0.98) (0.91) (0.97) (0.87) (1.16) (1.16) (1.23) (1.22)
No Information (N=17)
1.38 1.69 1.54 1.37 1.39 1.47 1.35 1.25 1.99 2.36 2.03 2.07
(0.61) (0.82) (0.70) (0.66) (1.08) (1.04) (0.88) (0.83) (0.84) (1.05) (0.79) (0.88)
Pro-biotech Information only (N=20)
1.30 1.37 1.74 1.24 1.49 1.46 1.62 1.29 2.33 2.33 2.54 2.21
(0.90) (0.71) (0.83) (0.83) (1.16) (0.88) (1.01) (1.06) (1.22) (1.15) (0.99) (1.23)
Anti-biotech Information only (N=17)
1.21 1.60 1.07 1.14 1.24 1.67 0.95 0.98 2.19 2.71 1.84 1.81
(0.72) (0.73) (0.83) (0.84) (0.93) (0.97) (0.81) (0.74) (0.85) (0.96) (1.20) (1.13)
Pro-biotech & Anti-biotech Information (N=21)
1.45 1.58 1.56 1.22 1.48 1.73 1.60 1.25 2.34 2.43 2.45 2.18
(0.79) (0.76) (0.99) (0.76) (0.86) (0.87) (1.11) (0.83) (1.19) (1.14) (1.42) (1.22)
Pro-biotech, Anti-biotech, and Verifiable Information (N=17)
1.03 1.07 1.08 1.03 1.23 1.22 1.19 1.09 1.86 1.86 1.83 1.66
(0.73) (0.76) (0.78) (0.84) (0.93) (0.82) (0.87) (0.88) (1.56) (1.42) (1.51) (1.59)
Notes: Average bid prices are in dollars. Standard deviations are presented in parentheses.
information treatments are greater than for generic GM, which in turn are higher than for Transgenic
GM labeled products.
Tables 4, 5, and 6 present differences in mean bid prices across a selection of different labels.
Table 4 presents a comparison between bid prices for GM Free vs. Intragenic GM and GM Free vs.
Transgenic GM labeled products, without enhanced nutrient labels. Consumers are willing to pay
a premium for GM Free over Transgenic GM labeled products under all information treatments.
Average premiums under different information treatments range from $0.03 to $0.46 per pound of
broccoli, $0.13 to $0.69 per pound of tomatoes, and $0.13 to $0.90 per five pounds of potatoes.
In general, participants are willing to pay premiums for GM Free over Intragenic GM labeled
products that are smaller, or even negative (e.g., under the pro-biotechnology treatment). Participants
receiving anti-biotech information are willing to pay the greatest premium for GM Free labeled
products.
A comparison of average bid prices for GM labeled products with and without enhanced nutrient
labels are presented in table 5. The first part of table 5 considers products with intragenic labels;
differences are positive, implying that consumers value enhanced antioxidants and vitamin C.
Premiums are the greatest under the pro-biotech information treatment and least under the anti-
biotech treatment. The second part of the table presents mean differences in bid prices for Transgenic
GM labeled products with and without enhanced nutrient labels. Here the differences are smaller
and–in the case of anti-biotech information and the pro, anti and third-party information treatments–
differences are slightly negative but not significantly different from zero. Combined, these results
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Table 3. Mean Bid Prices for Foods with Enhanced Nutrient Label
GMF Intra Trans GMF Intra Trans GMF Intra Trans
All Treatments (N=98)
1.51 1.67 1.45 1.42 1.76 1.41 2.45 2.61 2.27
(1.01) (1.14) (1.01) (0.86) (1.26) (0.97) (1.76) (1.84) (1.96)
No Information (N=20)
1.91 1.86 1.83 1.65 1.95 1.73 3.18 3.20 3.23
(1.54) (1.16) (1.28) (1.23) (1.34) (1.32) (3.06) (2.73) (3.40)
Pro-biotech Information only (N=18)
1.63 2.52 1.79 1.81 2.64 1.90 2.73 3.49 2.65
(0.65) (1.20) (0.68) (0.70) (0.94) (0.68) (1.00) (1.89) (1.35)
Anti-biotech Information only (N=18)
1.25 1.07 1.06 1.23 1.10 0.98 2.12 1.92 1.71
(0.82) (0.89) (0.89) (0.69) (0.66) (0.63) (1.46) (1.34) (1.37)
Pro-biotech & Anti-biotech Information (N=20)
1.67 1.84 1.63 1.36 1.74 1.43 2.54 2.64 2.34
(0.87) (1.15) (1.04) (0.67) (1.32) (1.04) (1.14) (1.45) (1.24)
Pro-biotech, Anti-biotech, and Verifiable Information (N=22)
1.10 1.16 0.97 1.11 1.44 1.05 1.74 1.90 1.48
(0.77) (0.70) (0.74) (0.75) (1.38) (0.72) (0.98) (0.87) (0.97)
Notes: Average bid prices are in dollars. Standard deviations are presented in parenthesis.
Table 4. Difference in Mean Bid Prices for Foods without Enhanced Nutrient Label
GM Free w/o EN GM Free w/o EN
vs. Intragenic w/o EN vs. Transgenic w/o EN
Info Treatment Broccoli Tomato Potato Broccoli Tomato Potato
No info $0.15 $0.12 $0.33 $0.32 $0.22 $0.29
Pro $− 0.36 $− 0.16 $− 0.21 $0.13 $0.17 $0.13
Anti $0.53∗∗ $0.72∗∗ $0.87∗∗ $0.46∗∗ $0.69∗∗ $0.90∗∗
Pro & Anti $0.01 $0.13 $− 0.01 $0.36 $0.49∗ $0.25
Pro, Anti, & Ver $− 0.01 $0.02 $0.03 $0.03 $0.13 $0.20
Notes: Asterisk (*) and double asterisk (**) denote variable significant at 10% and 5% respectively.
show that consumers value enhanced nutrition in fresh vegetables but are willing to pay a greater
premium when these traits are obtained through intragenics instead of transgenics. The first part of
table 6 compares bid prices for Intragenic GM labeled products with enhanced nutrient labels versus
Plain Label products without enhanced nutrient labels. Across all treatments, except for anti-biotech,
consumers are willing to pay a premium for the Intragenic GM labeled products with enhanced
nutrient labels. The second part of table 6 is a comparison between Transgenic GM labeled products
with enhanced nutrient labels versus Plain Label products. Here the differences are smaller and
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Table 5. Difference in Mean Bid Prices for Foods with and without Enhanced Nutrient Label
Intragenic w/ EN Transgenic w/ EN
vs. Intragenic w/o EN vs. Transgenic w/o EN
Info Treatment Broccoli Tomato Potato Broccoli Tomato Potato
No info $0.32 $0.60 $1.17∗ $0.46 $0.48 $1.16
Pro $0.78∗∗ $1.02∗∗ $0.95∗ $0.55∗∗ $0.61∗∗ $0.44
Anti $0.00 $0.14 $0.08 $− 0.08 $− 0.01 $− 0.10
Pro & Anti $0.27 $0.14 $0.19 $0.41 $0.18 $0.16
Pro, Anti, & Ver $0.09 $0.25 $0.06 $− 0.06 $− 0.04 $− 0.18
Notes: Asterisk (*) and double asterisk (**) denote variable significant at 10% and 5% respectively.
Table 6. Difference in Mean Bid Prices for Foods with Enhanced Nutrient Label and Plain
Label Foods
Intragenic w/ EN Transgenic w/ EN
vs. Plain Label w/o EN vs. Plain Label w/o EN
Info Treatment Broccoli Tomato Potato Broccoli Tomato Potato
No info $0.48 $0.56 $1.21∗ $0.45 $0.34 $1.24
Pro $1.22∗∗ $1.15∗∗ $1.16∗∗ $0.49∗ $0.41 $0.32
Anti $− 0.14 $− 0.14 $− 0.27 $− 0.15 $− 0.26 $− 0.48
Pro & Anti $0.39 $0.26 $0.30 $0.18 $− 0.05 $0.00
Pro, Anti, & Ver $0.13 $0.21 $0.04 $− 0.06 $− 0.18 $− 0.38
Notes: Asterisk (*) and double asterisk (**) denote variable significant at 10% and 5% respectively.
negative in the conflicted information setting with anti-, pro-, and verifiable-information. Table 6
provides additional evidence on the positive value placed by consumers on nutrition derived through
intragenics.
Impacts of Controversial and Verifiable Information on WTP
Although the data and unconditional analysis are suggestive of the impact of information on the
valuation of various types of GM products, a more rigorous analysis of bid prices is necessary to
identify label and information effects. In this section, a multivariate regression model is constructed
for this task.
Before deriving the econometric model, it is useful to summarize the issues that need to be
incorporated in a model of bid prices. Bids for a given type of produce may be correlated in
successive rounds of bidding. While it is common in the experimental economics literature to
ignore correlation across rounds, efficiency can be gained by incorporating this information into
the estimation procedure. Given the potential diversity of relative preferences for the experimental
products, a general error specification is a natural starting place for estimation. Hence, a seemingly
unrelated regression (SUR) model (Zellner, 1962) is selected to account for correlation across rounds
of bidding.
Zero bids raise special problems in bid price models. A zero bid could represent a participant’s
protest of GMOs; but more generally, a zero bid for a product presents a censoring problem (i.e., bid
prices are restricted to the non-negative interval). In the case of single equation models, censoring
can be easily managed (e.g., a Tobit model). In the case of a system of equations with censoring,
there are a number of classical estimation techniques that have been proposed, but they suffer from a
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variety of econometric issues and general intractability, particularly for models with larger numbers
of equations and cross-equation correlation of disturbances (e.g., a SUR-Tobit model). A SUR-
Tobit model is difficult to estimate because multiple integrals are required for maximum likelihood
estimation, requiring simulation algorithms (Huang, Sloan, and Adamache, 1987; Meng and Rubin,
1996; Huang, 1999).
An alternative, selected for this study, is to estimate the model via Bayesian techniques with data
augmentation (Albert and Chib, 1993). In this approach the complication of multiple integrals in
the SUR-Tobit model is eliminated and replaced with a straightforward Gibbs sampler, which is fast
to estimate and easily scaled to larger order systems. To simultaneously address these econometric
issues, Huang’s (2001) model is adapted and extended to create a Bayesian-SUR-Tobit model of
individual bid prices with commodity-specific-fixed effects.
Let yi j denote the bid price by an individual, i= 1,2, ...,N, for a food product with label j =
1,2, ...,J (J = 4 for the auctions without enhanced nutrient labels and J = 3 for the auctions with
enhanced nutrient labels). The latent WTP of the ith individual for the food product under label j
can be expressed as:
(1) y∗i j = x
′
ikβ j + εi j, i= 1,2, ...,N, j = 1,2, ...,J,
where:
(2) yi j =
 y
∗
i j if y
∗
i j > 0
0 if y∗i j ≤ 0,
where yi j is the observed bid price, y∗i j is the latent bid price, and ε = (εi1, ...,εiJ)′iid ∼N(0,Ω). For
individual i, we can express a system of equations, one equation for each label j = 1,2, ...,J, as:
(3)

y∗i1
y∗i2
...
y∗iJ
=

x′i1 0 · · · 0
0 x′i2 · · · 0
...
...
. . .
...
0 0 · · · x′iJ


β1
β2
...
βJ
+

εi1
εi2
...
εiJ
 .
In stacked notation, for each individual, i, we can express the system of WTP equations as y∗i =
xiβ + εi, i= 1,2, ...,N, where y∗i = (y∗i1, ...,y
∗
iJ) is a Jx1 vector, xi = diag(xi1, ...,xiJ) is a Jxk matrix,
and β = (β ′1, ...,β
′
J is a Jkx1 vector. Finally, stacking over all N individuals we have a complete
system of equations y∗ = Xβ + ε .
Following Albert and Chib (1993), latent bid prices are model parameters, and the augmented
posterior density function for unknown model parameters is proportional to the product of two
conditional distributions and the prior:
(4) p(β ,Ω,y∗|y)∝ p(y|y∗,β ,Ω)p(y∗|β ,Ω)p(β ,Ω).
The conditional distribution function for y is directly predicted by the latent bid price outcomes:
(5) p(y|y∗,β ,Ω) =
N
∏
i=1
J
∏
j=1
{I(y∗i j > 0)I(yi j = y∗i j) + I(y∗i j ≤ 0)I(yi j = 0)},
and the conditional distribution function for y∗ is proportional to:
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(6) p(y∗|β ,Ω)∝
N
∏
i=1
{|Ω|−N/2exp[−1
2
N
∑
i=1
(y∗i − xiβ )Ω−1(y∗i − xiβ )]}.
Priors for the unknown model parameters, β and Ω, are assumed to be independent:
(7)
β ∼N(β0,Vβ )
Ω−1 ∼W (aε ,Vε)
,
where N and W denote the multivariate normal and Wishart distributions. The conditional posterior
distributions for β and Ω−1 are given by standard results:
(8) β |Ω−1,y∼N(Dβdβ ,Dβ ),
where
(9)
Dβ = (X ′(Ω−1 ⊗ IN)X +V−1β )−1
dβ = X ′(Ω−1 ⊗ IN)y +V−1β β0
,
and
(10) Ω−1|β ,y∼W (N + aε , [V−1ε +
N
∑
i=1
(yi − Xiβ )(yi − Xiβ )]−1).
Finally, the conditional posterior for latent bids is a multivariate truncated normal given by:
(11) y∗i j|β ,Ω−1 ∼ T N[−∞,0](µ j|− j,ω2j|− j)∀i js.t.yi j = 0,
where:
(12)
µ j|− j = µ j +Ω′j− jΩ
−1
− j− j(y
∗′− j − µ− j)
ω2j|− j =ω
2
j j −Ω′j− jΩ−1− j− jΩ′j− j
,
where µ = Xiβ , µ j is the jth row element of µ , and µ− j is obtained by deleting the jth row element
of µ . The matrix Ω− j− j is derived from Ω by eliminating the jth column and row and Ω j− j is the
vector derived from the jth column of Ω by removing the jth row term. Iteratively sampling from
the conditional posterior distributions for β , Ω−1, and y∗ yields a set of draws from the joint pdf.
Econometric Results
We separate observations of bid prices into one set without enhanced nutrient labels and one
with enhanced nutrient labels and fit the Bayesian-SUR-Tobit model developed in the previous
section to these two groups separately. Instead of estimating a separate model for each food product
(fresh broccoli, tomatoes, and potatoes), the model is further stacked over the three commodities,
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and a commodity-specific fixed effects is added for each commodity. These dummy variables
are accompanied in each of the models by the socio-demographic variables presented in table 1,
including individual characteristics (e.g., income, education), personal opinions and knowledge
regarding genetic modification, and several health status indicators. Key values of parameters in
the priors β0 = 0,Vβ = (10e4)I j, aε = J∗k, and Vε = (10e4)I j, allowing the econometric results to
be dominated by the sample information and not the priors. Following a 1,000 iteration burn-in, a
total of 10,000 draws from the Gibbs sampler were used in estimation.
Following the tradition of Bayesian econometrics, we present empirical results for the posterior
mean of key parameters and their standard deviations and posterior probability of the estimated
parameter being greater than zero (Koop, Poirier, and Tobias, 2007). Table 7 presents estimates of
the bid price model for commodities without enhanced nutrients. A table of corresponding marginal
effects (abbreviated M.E.) is presented in the appendices as table A1.
The signs of the estimated posterior means of the information treatment dummy variables are
consistent with expectations. Individuals who receive anti-biotech information are willing to pay a
premium for the GM Free label (M.E. $0.054) and discount both the Intragenic GM and Transgenic
GM labels (M.E. $-0.120 and $-0.228). For individuals who receive only pro-biotech information,
the situation is reversed, with higher WTP for Intragenic and Transgenic GM labels (M.E. $0.120
and $0.082) and lower WTP for the GM-Free label (M.E. $-0.066).
Individuals who receive pro- and anti-biotech information treatments have greater WTP for all
four types of labels. However, the impact on relative WTP for Intragenic GM vs. GM Free and
Transgenic GM vs. GM Free labels is less than when participants receive pro-biotech information in
isolation. This indicates that, in combination, the anti-biotech information dampens the augmenting
impact that pro-biotech information has on WTP for GM labels relative to GM Free. Individuals
who received the combined pro, anti, and third party perspectives show reduced WTP for all four
labels. While the marginal impact is similar for each of the four labels, the largest reduction occurs
for the GM Free label.
We can also see that individuals who are older, white, have larger households, and have higher
household incomes are willing to pay more for foods with each of the four labels. Individuals with
affiliations to environmental groups have a negative posterior mean for each label; as expected, and
the decrease in WTP among this group is most pronounced for the Transgenic GM label and least
for the GM Free label (M.E. $-0.592 and $-0.174).
Results for the opinion variables present an interesting picture. Individuals who typically read
food labels–signaling an interest in the nutrient content of foods–have lower WTP for all four labels,
but the marginal effect is most pronounced for Intragenic and Transgenic GM labels. Individuals
who are more informed about GM coming into the experiments are willing to pay more than their
counterparts for Transgenic GM label and Plain label foods in particular. However, individuals with
a positive opinion of GM coming into the experiments have a posterior mean close to zero across
the four labeling treatments, indicating that the information treatments, in part, confounded prior
opinions of GM.
Results for the healthy attitude proxies are mixed. While the signs of the posterior means for
smoking (a negative attitude), regular exercise (a positive attitude), and highly rated healthiness of
diet (a positive attitude) are consistent across the four food labels, there is little variation in the
magnitude of the marginal effect across the different products.
Finally, results show a significant first-round bidding or framing effect. Specifically, participants
bid relatively more in the first round for some labels. Our results also show that error terms in the
bid price equations are positively correlated. For example, the estimated correlation between error
terms for rounds with the Plain and Intragenic GM labels is 0.51 and between rounds with Plain
and Transgenic GM labels is 0.31. Despite the greater modeling burden, taking account of the cross-
label/round error correlations raises the efficiency of estimation.
Table 8 summarizes the econometric model of bid prices for food products with enhanced
nutrient labels (corresponding marginal effects are presented in table A2 in the appendices).
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The posterior mean is positive across all three labels for individuals receiving the pro-biotech
information treatment, with the greatest relative increase for the Intragenic GM label. Individuals
who receive anti-biotech information have reduced WTP for all three labels. In combination,
individuals receiving both the pro- and anti-biotech information have a lower WTP for the GM
and Transgenic GM labels, but higher for the Intragenic GM label. This indicates that these two
perspectives in combination largely counterbalance each other in terms of their impact on valuations,
but the positive impact on WTP for the Intragenic GM label still holds marginally. Finally, when
verifiable information is introduced, valuations for all three labels are lower, indicating that verifiable
information bolsters the negative impact of anti-biotech information on WTP for GM food products
with enhanced consumer attribute labels.
Individuals who are members of environmental groups, have experience in farming, are white,
or have higher household incomes have lower WTP for all three GM labels. Consumers who
are older or have larger households have a higher WTP. Consistent with the results for products
without enhanced nutrient labels, individuals who were informed about GM before the experiments
or typically read food labels are willing to pay more for each of the three labels. Interestingly,
individuals with a favorable prior opinion towards GM are willing to pay more for both the GM and
Transgenic GM labels, but the posterior is flat and centered at zero for the Intragenic GM label. This
indicates that prior perceptions toward GM did not carry over into valuations of the Intragenic GM
with enhanced nutrition label.
As in the estimates for products without enhanced nutrient labels, the signs of the posterior
estimates for the healthy attitude variables do not present a clear relation with WTP. Surprisingly,
individuals who regularly exercise or smoke are willing to pay more for each of the three labels,
but those with self-assessed healthier diets are willing to pay less. However, individuals who have
higher self-assessed physical healthiness are willing to pay more under each of the three labels.
Finally, as in the case of products without enhanced nutrient labels, a significant first-round
label effect and correlation of error terms across rounds of bidding/labels occurs. The correlation
coefficients across the different labels is approximately 0.5, which is large and consistent with the
cross-label correlations in bid prices for products without enhanced nutrient labels.
Discussion
In the effort to improve health outcomes in the United States, current policy objectives focus on
encouraging consumption of healthy alternatives, including fruits, vegetables, and whole grains.
In addition to typically being lower-calorie options compared to alternatives, fruits and vegetables
in particular make important dietary contributions to overall health quality and may reduce
potential health risks. One potential strategy for increasing both potency and consumption of these
foods is improving the nutritional value and appeal of fruits and vegetables. By departing from
fortification approaches, biotechnology companies have developed new “healthier” varieties via
controversial genetic methods that would not be feasible using standard plant breeding techniques.
Our experimental evidence indicates that potential exists for genetically modified foods containing
enhanced vitamin and antioxidant content to find acceptance among consumers, with several
important caveats.
Our experiments indicate that information brought to the public’s attention by interested parties
attempting to influence market outcomes plays an important role in determining acceptance of
GM foods with enhanced nutrients. While pro-biotechnology information in isolation has a strong
augmenting impact on WTP, the premium consumers are willing to pay declines significantly in a
crowded information environment with positive, negative, and verifiable information. Additionally,
experiments indicate that the very nature of the engineering process has an effect on consumer WTP
for nutritionally enhanced foods. Consumers appear to be more accepting of nutrition enhancements
achieved using intragenics, which is arguably closer to conventional plant breeding methods,
compared to transgenics, where “foreign” genetic material outside of the species is used, indicating
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that intragenics may be a more appealing product development path for biotechnology companies
attempting to bring enhanced food products to market.
[Received September 2010; final revision received June 2011.]
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Appendix A: Environmental Group Perspective on GM
General Information
Genetic modification (GM) takes genes from one organism and places then into another. The process
lets scientists manipulate genes in an unnatural way. Inadequate safety testing of GM plants and
food products has occurred. Humans and the Earth are being used as guinea pigs for testing whether
“Frankenfoods” are safe. GM foods should be banned because their effect on consumers and the
environment is unknown and potentially catastrophic! Genetic modification is one of the most risky
things being done to your food sources today and should be stopped before more damage is done.
Scientific Impact
All genetic modifications of plants are risky. All GM techniques are relatively new and no one can
guarantee that consumers or the environment will not be harmed. The biggest potential hazard of
GM foods is the unknown.
Human Impact
Genetically modified foods could pose serious risks to human health. Some foods contain allergens,
and the potential exists for allergens to be transferred into a GM food product that no one would
suspect. For example, if the genes from a peanut were transferred into a tomato, and someone who
is allergic to peanuts eats this GM tomato, he could display a peanut allergy.
Another problem with transgenic foods is a moral issue. Many GM techniques transfer genes
across species. We believe it is morally wrong to alter life forms on such a fundamental level.
Financial Impact
GM foods are being pushed onto consumer by big businesses which only care about their own profits
and ignore possible negative side effects. These groups are actually patenting new life forms they
create with plans to sell for profits. Studies have shown that GM crops may even get lower yields
than conventional crops.
Environmental Impact
GM foods could pose major environmental hazards. Little testing of GM plants for environmental
impacts has occurred. One potential risk of GM crops is their impact on wildlife, including wild
species of plants and insects. A study showed that one type of GM plant killed Monarch butterflies.
Another potential environmental hazard could come from pests that become resistant to new
naturally occurring toxic substances engineered into plants to kill pests–insects and worms– or to
make a plant resistant to a particular herbicide application. The target pests that get exposed to these
new GM crops could quickly develop tolerances and wipe out many of the potential advantages of
GM pest resistance.
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Appendix B: Biotechnology Industry Perspective on GM
General Information
Genetically modified (GM) plants have the potential to be one of the greatest discoveries in the
history of farming. GM crops have lowered food production costs by improving insect and disease
resistance and weed control in plants. New genetic engineering techniques could dramatically
enhance consumer benefiting attributes of food such as vitamins, antioxidants, flavor, and shelf life.
These improvements to plant quality can only be attained through GM, not conventional breeding.
The process of genetic modification takes genes from one organism and places them into another.
There are two distinct types of GM used by biotechnology companies. Transgenic GM transfers
genes between two unrelated organisms, for example from soil bacteria to corn. Intragenic GM
involves transferring genes between two breeds of the same organism, for example, from wild
species of corn to a commercial variety of corn.
Scientific Impact
Both transgenic and intragenic techniques are used to produce food products that are approved
by the Food and Drug Administration (FDA). Intragenic modification is a genetic technique
for significantly speeding up the conventional process of plant cross-breeding, which has been
undertaken by farmers and plant breeders for thousands of years. Many industry groups believe
intragenics should require minimal FDA testing because no foreign genes or proteins are added to
the GM plant. We have only seen the tip of the iceberg of the future potential of GM for improving
worldwide health and nutrition through enhanced plants.
Human Impact
The potential exists for GM to dramatically enhance traits that have direct value to consumers,
such as increased vitamins and antioxidants, more flavor, longer shelf life, lower pesticide use,
and reduced cost of production. Superior GM plants will help reduce worldwide malnutrition and
improve the healthiness of foods. The FDA has approved GM food for human consumption, and
Americans have been consuming GM foods for a decade. While every food (modified or not) poses
some risks, there has never been a documented case of a person getting sick from GM food.
Financial Impact
With the introduction of enhanced nutrition, antioxidants, shelf life, flavors, and other consumer-
desired attributes using GM technology, consumers will for the first time enjoy the direct benefits
of genetic engineering. GM plants have reduced farmers’ costs, which mean lower food prices.
Worldwide the number of hungry people is declining. GM technology is helping to feed the world
and improve worldwide nutrition.
Environmental Impact
Genetic modification of plants has the potential to be one of the most environmentally helpful
discoveries ever. GM technology has produced new methods of insect control that reduce chemical
insecticide application by 50% or more. GM weed control is providing new methods to control
weeds, which are a problem in no-till farming. This means greater crop yields and less environmental
damage.
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Appendix C: Independent, 3rd Party, Verifiable Perspective on GM
General Information
The process of genetic modification (GM) takes genes from one organism and places them into
another. There are two distinct types of GM used by biotechnology companies. Transgenic GM
transfers genes between two unrelated organisms, for example, from soil bacteria to corn. Intragenic
GM involves transferring genes between two varieties of the same organism, for example, from wild
species of corn to a commercial variety. Hence, intragenic modification has much in common with
conventional plant breeding.
Scientific Impact
The Food and Drug Administration (FDA) standard for GM food products is based on the principle
that they have essentially the same ingredients, although modified from the original plant. Almost
all GM crops meet the FDA’s substantive equivalent requirement. Hence, they do not require special
testing before commercial marketing can occur.
Human Impact
Many scientists see intragenics as having real potential for enhancing consumer attributes of
plants such as dramatically increasing vitamin and antioxidant levels, extending shelf life, and
reduced chemical pesticide application without concerns about gene transfer across species. These
improvements to plants are only possible using genetic modification and not conventional breeding.
All foods present a risk of an allergic reaction to a small fraction of the population. No FDA
approved GM food poses any known unique human health risks, but when genes are transferred
across species, a new allergen is possible. This is more likely with transgenics than intragenics.
While GM crops can result in higher yields and enhanced nutrition, there is no consensus whether
GM foods have or will reduce worldwide hunger.
Many people have moral or religious objections to GM. Some groups see intragenics as being
more acceptable because genes are transferred between two breeds of the same species.
Financial Impact
GM seeds and other organisms are produced by businesses that seek profits. For farmers to switch
to GM crops, they must see benefits from making a change. Consumers must also see benefits from
consuming GM foods–lower price or enhanced consumer attributes. However GM technology may
lead to changes in the organization of the agri-business industry and farming.
Environmental Impact
The long-term effects of GM on the environment are largely unknown. Bioengineered insect
resistance has reduced farmers’ applications of environmentally hazardous insecticides, but
resistance to this bio-control system will increase over time. More studies are occurring to help
assess the impact of bioengineered plants on the environment. Some studies reported harm to
Monarch butterflies from GM crops, but other scientists were not able to recreate the results.
Enhanced consumer attributes, such as vitamins, antioxidants, and longer shelf life due to
intragenics pose no known environmental hazards.
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Table A1. Marginal Effects of Explanatory Variables on Bid Prices for Products Without
Enhanced Nutrient Label (N=92, Obs=1,104)
Y PlainLabel Y GMFree Y Intragenic Y Transgenic
Dep Var Mean Stdev Mean Stdev Mean Stdev Mean Stdev
Information Treatment Dummy Variables (No Information Dummy Omitted)
Pro 0.048 0.090 -0.066 0.090 0.120 0.084 0.082 0.132
Anti -0.084 0.132 0.054 0.066 -0.120 0.150 -0.228 0.198
Pro & Anti 0.108 0.072 0.066 0.054 0.156 0.072 0.060 0.108
Pro, Anti, & Ver -0.072 0.120 -0.120 0.114 -0.006 0.114 -0.102 0.156
Demographic Variables
Gender -0.060 0.066 -0.018 0.054 0.036 0.090 -0.132 0.084
Race 0.330 0.174 0.120 0.102 0.204 0.150 0.210 0.168
Age 0.012 0.000 0.006 0.000 0.006 0.000 0.012 0.000
Income 0.000 0.000 0.000 0.000 0.000 0.000 0.006 0.000
Educ 0.000 0.012 -0.006 0.006 0.012 0.012 0.018 0.012
Married -0.072 0.072 -0.024 0.048 -0.096 0.078 -0.108 0.090
Household 0.060 0.024 0.060 0.018 0.048 0.024 0.054 0.030
Iowa -0.090 0.060 -0.060 0.042 -0.060 0.066 0.090 0.090
Farm 0.000 0.072 0.030 0.048 0.042 0.072 0.078 0.084
Envi_Mem -0.474 0.390 -0.174 0.222 -0.288 0.324 -0.592 0.522
Opinion Variables
Informed 0.138 0.066 0.060 0.060 -0.006 0.120 0.132 0.108
Opinion -0.036 0.090 0.012 0.060 0.024 0.084 -0.096 0.132
Read_Labels -0.138 0.078 -0.030 0.054 -0.090 0.078 -0.270 0.096
Health Variables
Smoke 0.150 0.054 0.120 0.042 0.120 0.060 0.150 0.078
Exercise 0.024 0.072 0.036 0.054 0.198 0.084 0.108 0.096
Health_Diet 0.024 0.024 0.024 0.018 -0.006 0.024 0.042 0.030
Health_Phys -0.024 0.018 -0.018 0.012 -0.024 0.024 -0.048 0.024
Round 1 Label 0.054 0.030 0.048 0.030 0.114 0.036 0.138 0.036
Notes: Mean and Stdev denote the posterior mean, E(·|y), and posterior standard deviation, Std(·|y).
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Table A2. Marginal Effects of Explanatory Variables on Bid Prices for Products with
Enhanced Nutrient Label (N=98, Obs=882)
Y GM Y Intragenic Y Transgenic
Dep Var Mean Stdev Mean Stdev Mean Stdev
Information Treatment Dummy Variables (No Information Dummy Omitted)
Pro 0.040 0.056 0.140 0.034 0.136 0.094
Anti -0.034 0.072 -0.122 0.080 -0.142 0.132
Pro & Anti -0.026 0.068 0.026 0.050 -0.092 0.122
Pro, Anti, & Ver -0.226 0.092 -0.142 0.074 -0.182 0.122
Demographic Variables
Gender -0.010 0.040 0.048 0.038 0.084 0.074
Race -0.086 0.046 -0.080 0.038 -0.138 0.084
Age 0.008 0.002 0.004 0.002 0.010 0.004
Income -0.002 0.000 -0.002 0.000 -0.006 0.002
Educ -0.006 0.012 0.020 0.010 -0.002 0.026
Married -0.018 0.050 -0.082 0.042 0.008 0.086
Household 0.082 0.022 0.058 0.020 0.082 0.044
Iowa -0.042 0.040 -0.052 0.034 0.118 0.076
Farm -0.140 0.070 -0.128 0.064 -0.106 0.100
Envi_Mem -0.118 0.146 -0.140 0.144 -0.098 0.202
Opinion Variables
Informed 0.030 0.066 0.026 0.056 0.078 0.112
Opinion 0.088 0.048 -0.012 0.060 0.216 0.084
Read_Labels 0.132 0.056 0.076 0.046 0.024 0.082
Health Variables
Smoke 0.068 0.040 0.036 0.038 0.046 0.076
Exercise 0.038 0.042 0.116 0.042 0.136 0.076
Health_Diet -0.014 0.024 -0.036 0.022 -0.060 0.054
Health_Phys 0.056 0.024 0.036 0.022 0.092 0.056
Round 1 Label -0.054 0.030 0.064 0.026 0.188 0.048
Notes: Mean and Stdev denote the posterior mean, E(·|y), and posterior standard deviation, Std(·|y).
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